These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24966600)

  • 1. Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.
    Nakamura I
    World J Gastroenterol; 2014 Jun; 20(23):7298-305. PubMed ID: 24966600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients.
    Nakamura I; Ochiai K; Imai Y; Moriyasu F; Imawari M
    Hepatol Res; 2007 Dec; 37(12):1062-7. PubMed ID: 17608669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids.
    Nakamura I; Ochiai K; Imawari M
    Hepatol Res; 2004 Aug; 29(4):207-211. PubMed ID: 15288012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
    Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
    Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease.
    van Dijk AM; Bruins Slot AS; Portincasa P; Siegerink SN; Chargi N; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
    Eur J Clin Invest; 2023 Mar; 53(3):e13909. PubMed ID: 36394355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
    Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
    Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
    Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of branched-chain amino acid-enriched nutrient mixture on natural killer cell activity in viral cirrhosis.
    Takegoshi K; Nanasawa H; Itoh H; Yasuyama T; Ohmoto Y; Sugiyama K
    Arzneimittelforschung; 1998 Jun; 48(6):701-6. PubMed ID: 9689432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
    Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
    Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
    Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T; Nagai H; Kanayama M; Sumino Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture.
    Nakaya Y; Harada N; Kakui S; Okada K; Takahashi A; Inoi J; Ito S
    J Gastroenterol; 2002; 37(7):531-6. PubMed ID: 12162411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial.
    Siramolpiwat S; Limthanetkul N; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N
    BMC Gastroenterol; 2023 May; 23(1):154. PubMed ID: 37189033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early administration of branched-chain amino acid granules.
    Ishikawa T
    World J Gastroenterol; 2012 Sep; 18(33):4486-90. PubMed ID: 22969221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis.
    Hidaka H; Nakazawa T; Kutsukake S; Yamazaki Y; Aoki I; Nakano S; Asaba N; Minamino T; Takada J; Tanaka Y; Okuwaki Y; Watanabe M; Shibuya A; Koizumi W
    J Gastroenterol; 2013 Feb; 48(2):269-76. PubMed ID: 22825550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus.
    Kobayashi M; Ikeda K; Arase Y; Suzuki Y; Suzuki F; Akuta N; Hosaka T; Murashima N; Saitoh S; Someya T; Tsubota A; Kumada H
    J Gastroenterol; 2008; 43(1):63-70. PubMed ID: 18297438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.
    Yoshida T; Muto Y; Moriwaki H; Yamato M
    Gastroenterol Jpn; 1989 Dec; 24(6):692-8. PubMed ID: 2606303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis.
    Miyake T; Abe M; Furukawa S; Tokumoto Y; Toshimitsu K; Ueda T; Yamamoto S; Hirooka M; Kumagi T; Hiasa Y; Matsuura B; Onji M
    Intern Med; 2012; 51(16):2151-5. PubMed ID: 22892494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
    Terakura D; Shimizu M; Iwasa J; Baba A; Kochi T; Ohno T; Kubota M; Shirakami Y; Shiraki M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Carcinogenesis; 2012 Dec; 33(12):2499-506. PubMed ID: 23027617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.